Table 2.
Baseline laboratory data at admission.
| Total (n = 194) | Survivors (n = 121) | Nonsurvivors (n = 73) | P Value | |
|---|---|---|---|---|
| WBC, ×109/L | 12.4 (7.2–21.6) | 13.2 (7.4–23.0) | 11.8 (6.0–17.2) | 0.051 |
| Neutrophils, n (%) | 87.3 (80.9–92.4) | 88.7 (81.4–92.8) | 86.8 (80.3–91.9) | 0.437 |
| Hemoglobin, g/L | 109 (96–130) | 111 (97–131) | 106 (94–126) | 0.496 |
| Platelet, ×109/L | 176 (99–262) | 193 (121–286) | 143 (67–207) | 0.012∗ |
| Procalcitonin, ng/mL | 35.5 (8.0–100.0) | 35.2 (6.5–100.0) | 35.5 (13.8–100.0) | 0.885 |
| Lactate, mmol/L | 3.8 (2.3–7.2) | 3.3 (2.0–6.4) | 4.4 (2.7–8.3) | 0.025 |
| Creatinine, µmol/L | 149 (98–250) | 143 (88–226) | 173 (104–271) | 0.272 |
| Bilirubin total, µmol/L | 17.9 (11.1–39.9) | 17.7 (10.9–40.9) | 18.5 (11.5–36.0) | 0.902 |
| AST, u/l | 74 (37–152) | 69 (33–150) | 83 (42–195) | 0.233 |
| ALT, u/l | 41 (20–90) | 40 (19–90) | 45 (21–89) | 0.633 |
| Glucose, mmol/L | 7.5 (5.7–11.2) | 7.5 (5.7–11.2) | 7.8 (5.8–11.2) | 0.646 |
| Bacteremia | 62 (32.0) | 32 (26.4) | 30 (41.1) | 0.034 |
Data are introduced as median (interquartile range). AST, aspartate transaminase; ALT, alanine aminotransferase; WBC, white blood cell; ∗P < 0.05.